Understanding the genetic basis of gastric cancer: recent advances

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA. Cancer J. Clin. 61(2), 69–90 (2011).
   PubMed Web of Science ®Google Scholar
• Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 64, 31–49 (1965).
   PubMedGoogle Scholar
• Aarnio M, Salovaara R, Aaltonen LA, Mecklin JP, Järvinen HJ. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int. J. Cancer 74(5), 551–555 (1997).
   PubMed Web of Science ®Google Scholar
• Masciari S, Dewanwala A, Stoffel EM et al. Gastric cancer in individuals with Li–Fraumeni syndrome. Genet. Med. 13(7), 651–657 (2011).
   PubMedGoogle Scholar
• van Lier MG, Wagner A, Mathus-Vliegen EM, Kuipers EJ, Steyerberg EW, van Leerdam ME. High cancer risk in Peutz–Jeghers syndrome: a systematic review and surveillance recommendations. Am. J. Gastroenterol. 105(6), 1258–1264; author reply 1265 (2010).
   PubMed Web of Science ®Google Scholar
• Huntsman DG, Carneiro F, Lewis FR et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N. Engl. J. Med. 344(25), 1904–1909 (2001).
   PubMed Web of Science ®Google Scholar
• Guilford P, Humar B, Blair V. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice. Gastric Cancer 13(1), 1–10 (2010).
   PubMed Web of Science ®Google Scholar
• Oliveira C, Sousa S, Pinheiro H et al. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 136(7), 2137–2148 (2009).
   PubMed Web of Science ®Google Scholar
• Pharoah PD, Guilford P, Caldas C; International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121(6), 1348–1353 (2001).
   PubMed Web of Science ®Google Scholar
• Barber ME, Save V, Carneiro Fet al. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. J. Pathol. 216(3), 286–294 (2008).
   PubMedGoogle Scholar
• Humar B, Blair V, Charlton A, More H, Martin I, Guilford P. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res. 69(5), 2050–2056 (2009).
   PubMed Web of Science ®Google Scholar
• Mimata A, Fukamachi H, Eishi Y, Yuasa Y. Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. Cancer Sci. 102(5), 942–950 (2011).
   PubMed Web of Science ®Google Scholar
• Correa P. Helicobacter pylori and gastric carcinogenesis. Am. J. Surg. Pathol. 19(Suppl. 1), S37–S43 (1995).
   Google Scholar
• Correa P. Human gastric carcinogenesis: a multistep and multifactorial process – first American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res. 52(24), 6735–6740 (1992).
   PubMed Web of Science ®Google Scholar
• Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 2(7924), 58–60 (1975).
   PubMed Web of Science ®Google Scholar
• Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control 22(3), 375–387 (2011).
   PubMed Web of Science ®Google Scholar
• de Sablet T, Piazuelo MB, Shaffer CLet al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 60(9), 1189–1195 (2011).
   PubMedGoogle Scholar
• Ding SZ, Goldberg JB, Hatakeyama M. Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis. Future Oncol. 6(5), 851–862 (2010).
   PubMed Web of Science ®Google Scholar
• Polk DB, Peek RM Jr. Helicobacter pylori: gastric cancer and beyond. Nat. Rev. Cancer 10(6), 403–414 (2010).
   PubMed Web of Science ®Google Scholar
• Ding SZ, Minohara Y, Fan XJet al. Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect. Immun. 75(8), 4030–4039 (2007).
   PubMed Web of Science ®Google Scholar
• El-Omar EM, Carrington M, Chow WHet al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404(6776), 398–402 (2000).
   PubMed Web of Science ®Google Scholar
• Persson C, Canedo P, Machado JC, El-Omar EM, Forman D. Polymorphisms in inflammatory response genes and their association with gastric cancer: a HuGE systematic review and meta-analyses. Am. J. Epidemiol. 173(3), 259–270 (2011).
   PubMedGoogle Scholar
• Jorge YC, Duarte MC, Silva AE. Gastric cancer is associated with NOS2 -954G/C polymorphism and environmental factors in a Brazilian population. BMC Gastroenterol. 10, 64 (2010).
   PubMedGoogle Scholar
• Shen J, Wang RT, Wang LW, Xu YC, Wang XR. A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer. World J. Gastroenterol. 10(22), 3278–3283 (2004).
   PubMed Web of Science ®Google Scholar
• Goto Y, Ando T, Naito M, Goto H, Hamajima N. Inducible nitric oxide synthase polymorphism is associated with the increased risk of differentiated gastric cancer in a Japanese population. World J. Gastroenterol. 12(39), 6361–6365 (2006).
   PubMed Web of Science ®Google Scholar
• Jia Y, Persson C, Hou Let al. A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer. Cancer Causes Control 21(2), 313–321 (2010).
   PubMed Web of Science ®Google Scholar
• Oguma K, Oshima H, Oshima M. Inflammation, tumor necrosis factor and Wnt promotion in gastric cancer development. Future Oncol. 6(4), 515–526 (2010).
   PubMedGoogle Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 144(5), 646–674 (2011).
   PubMed Web of Science ®Google Scholar
• Ooi CH, Ivanova T, Wu Jet al. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet. 5(10), e1000676 (2009).
   PubMed Web of Science ®Google Scholar
• Hamilton JP, Meltzer SJ. A review of the genomics of gastric cancer. Clin. Gastroenterol. Hepatol. 4(4), 416–425 (2006).
   PubMedGoogle Scholar
• Werner M, Becker KF, Keller G, Höfler H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J. Cancer Res. Clin. Oncol. 127(4), 207–216 (2001).
   PubMed Web of Science ®Google Scholar
• Kim HS, Woo DK, Bae SI, Kim YI, Kim WH. Allelotype of the adenoma-carcinoma sequence of the stomach. Cancer Detect. Prev. 25(3), 237–244 (2001).
   PubMedGoogle Scholar
• Jiaqing L, Hokita S, Xiangming Cet al. Role of cyclin E and p53 expression in progression of early gastric cancer. Gastric Cancer 1(2), 160–165 (1998).
   PubMedGoogle Scholar
• Schraml P, Bucher C, Bissig Het al. Cyclin E overexpression and amplification in human tumours. J. Pathol. 200(3), 375–382 (2003).
   PubMed Web of Science ®Google Scholar
• Lee JH, Park SJ, Abraham SCet al. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 23(26), 4646–4654 (2004).
   PubMed Web of Science ®Google Scholar
• Kuzushita N, Rogers AB, Monti NAet al. p27kip1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice. Gastroenterology 129(5), 1544–1556 (2005).
   PubMedGoogle Scholar
• Tahara E. Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer 75(Suppl. 6), 1410–1417 (1995).
   PubMedGoogle Scholar
• Miki H, Ohmori M, Perantoni AO, Enomoto T. K-ras activation in gastric epithelial tumors in Japanese. Cancer Lett. 58(1–2), 107–113 (1991).
   PubMedGoogle Scholar
• Gong C, Mera R, Bravo JCet al. KRAS mutations predict progression of preneoplastic gastric lesions. Cancer Epidemiol. Biomarkers Prev. 8(2), 167–171 (1999).
   PubMedGoogle Scholar
• Bang YJ, Van Cutsem E, Feyereislova A et al. ; ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a Phase 3, open-label, randomised controlled trial. Lancet 376(9742), 687–697 (2010).
   PubMed Web of Science ®Google Scholar
• Alpízar-Alpízar W, Nielsen BS, Sierra Ret al. Urokinase plasminogen activator receptor is expressed in invasive cells in gastric carcinomas from high- and low-risk countries. Int. J. Cancer 126(2), 405–415 (2010).
   PubMedGoogle Scholar
• Chu YQ, Ye ZY, Tao HQ, Wang YY, Zhao ZS. Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma. World J. Gastroenterol. 14(13), 1990–1996 (2008).
   PubMedGoogle Scholar
• Lukaszewicz-Zajac M, Mroczko B, Szmitkowski M. Gastric cancer – the role of matrix metalloproteinases in tumor progression. Clin. Chim. Acta 412(19–20), 1725–1730 (2011).
   PubMed Web of Science ®Google Scholar
• Lee LY, Wu CM, Wang CCet al. Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression. Histol. Histopathol. 23(5), 515–521 (2008).
   PubMed Web of Science ®Google Scholar
• Holbrook JD, Parker JS, Gallagher KTet al. Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine. J. Transl. Med. 9(1), 119 (2011).
   PubMed Web of Science ®Google Scholar
• Park J, Song SH, Kim TYet al. Aberrant methylation of integrin α4 gene in human gastric cancer cells. Oncogene 23(19), 3474–3480 (2004).
   PubMedGoogle Scholar
• Zhao C, Bu X, Zhang N, Wang W. Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer. BMC Cancer 9, 224 (2009).
   PubMed Web of Science ®Google Scholar
• Ascaño JJ, Frierson H Jr, Moskaluk CA et al. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mod. Pathol. 14(10), 942–949 (2001).
   PubMed Web of Science ®Google Scholar
• Becker KF, Atkinson MJ, Reich U et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54(14), 3845–3852 (1994).
   PubMed Web of Science ®Google Scholar
• Oliveira C, Senz J, Kaurah Pet al. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum. Mol. Genet. 18(9), 1545–1555 (2009).
   PubMed Web of Science ®Google Scholar
• Tamura G, Yin J, Wang Set al. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J. Natl Cancer Inst. 92(7), 569–573 (2000).
   PubMed Web of Science ®Google Scholar
• Hara T, Ooi A, Kobayashi M, Mai M, Yanagihara K, Nakanishi I. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. Lab. Invest. 78(9), 1143–1153 (1998).
   PubMed Web of Science ®Google Scholar
• Hattori Y, Itoh H, Uchino Set al. Immunohistochemical detection of K-sam protein in stomach cancer. Clin. Cancer Res. 2(8), 1373–1381 (1996).
   PubMed Web of Science ®Google Scholar
• Kunii K, Davis L, Gorenstein Jet al. FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival. Cancer Res. 68(7), 2340–2348 (2008).
   PubMed Web of Science ®Google Scholar
• Zhao WM, Wang L, Park Het al. Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts. Clin. Cancer Res. 16(23), 5750–5758 (2010).
   PubMed Web of Science ®Google Scholar
• Kokkola A, Monni O, Puolakkainen Pet al. 17q12-21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparative genomic hybridization study. Genes. Chromosomes Cancer 20(1), 38–43 (1997).
   PubMed Web of Science ®Google Scholar
• Wu MS, Chang MC, Huang SPet al. Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer. Genes Chromosomes Cancer 30(1), 80–86 (2001).
   PubMedGoogle Scholar
• Weiss MM, Kuipers EJ, Postma Cet al. Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell. Oncol. 26(5–6), 307–317 (2004).
   PubMed Web of Science ®Google Scholar
• Tsukamoto Y, Uchida T, Karnan Set al. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J. Pathol. 216(4), 471–482 (2008).
   PubMed Web of Science ®Google Scholar
• Lee J, Seo JW, Jun HJet al. Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Oncol. Rep. 25(6), 1517–1524 (2011).
   PubMed Web of Science ®Google Scholar
• Tao J, Deng NT, Ramnarayanan Ket al. CD44–SLC1A2 gene fusions in gastric cancer. Sci. Transl. Med. 3(77), 77ra30 (2011).
   PubMedGoogle Scholar
• Kim H, An JY, Noh SH, Shin SK, Lee YC, Kim H. High microsatellite instability predicts good prognosis in intestinal-type gastric cancers. J. Gastroenterol. Hepatol. 26(3), 585–592 (2011).
   PubMedGoogle Scholar
• Falchetti M, Saieva C, Lupi Ret al. Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival. Hum. Pathol. 39(6), 925–932 (2008).
   PubMedGoogle Scholar
• Gazvoda B, Juvan R, Zupanic-Pajnic Iet al. Genetic changes in Slovenian patients with gastric adenocarcinoma evaluated in terms of microsatellite DNA. Eur. J. Gastroenterol. Hepatol. 19(12), 1082–1089 (2007).
   PubMedGoogle Scholar
• Corso G, Velho S, Paredes Jet al. Oncogenic mutations in gastric cancer with microsatellite instability. Eur. J. Cancer 47(3), 443–451 (2011).
   PubMedGoogle Scholar
• Velho S, Oliveira C, Paredes Jet al. Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours. Hum. Mol. Genet. 19(4), 697–706 (2010).
   PubMedGoogle Scholar
• Balassiano K, Lima S, Jenab Met al. Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Cancer Lett. 311(1), 85–95 (2011).
   PubMedGoogle Scholar
• Alves MK, Ferrasi AC, Lima VP, Ferreira MV, de Moura Campos Pardini MI, Rabenhorst SH. Inactivation of COX-2, HMLH1 and CDKN2A gene by promoter methylation in gastric cancer: relationship with histological subtype, tumor location and Helicobacter pylori genotype. Pathobiology 78(5), 266–276 (2011).
   PubMed Web of Science ®Google Scholar
• Park SY, Kook MC, Kim YWet al. CpG island hypermethylator phenotype in gastric carcinoma and its clinicopathological features. Virchows Arch. 457(4), 415–422 (2010).
   PubMedGoogle Scholar
• Fukayama M. Epstein–Barr virus and gastric carcinoma. Pathol. Int. 60(5), 337–350 (2010).
   PubMed Web of Science ®Google Scholar
• Oh HK, Tan AL, Das Ket al. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin. Cancer Res. 17(9), 2657–2667 (2011).
   PubMed Web of Science ®Google Scholar
• Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y. MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS ONE 6(1), e16617 (2011).
   Web of Science ®Google Scholar
• Bou Kheir T, Futoma-Kazmierczak E, Jacobsen Aet al. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol. Cancer 10, 29 (2011).
   PubMedGoogle Scholar
• Wu WK, Lee CW, Cho CHet al. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 29(43), 5761–5771 (2010).
   PubMed Web of Science ®Google Scholar
• Hippo Y, Taniguchi H, Tsutsumi Set al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 62(1), 233–240 (2002).
   PubMed Web of Science ®Google Scholar
• Nørsett KG, Laegreid A, Midelfart Het al. Gene expression based classification of gastric carcinoma. Cancer Lett. 210(2), 227–237 (2004).
   PubMedGoogle Scholar
• Boussioutas A, Li H, Liu Jet al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res. 63(10), 2569–2577 (2003).
   PubMedGoogle Scholar
• Dixon MF, Martin IG, Sue-Ling HM, Wyatt JI, Quirke P, Johnston D. Goseki grading in gastric cancer: comparison with existing systems of grading and its reproducibility. Histopathology 25(4), 309–316 (1994).
   PubMedGoogle Scholar
• Arslan Pagnini C, Rugge M. Gastric cancer: problems in histological diagnosis. Histopathology 6(4), 391–398 (1982).
   PubMedGoogle Scholar
• Palli D, Bianchi S, Cipriani Fet al. Reproducibility of histologic classification of gastric cancer. Br. J. Cancer 63(5), 765–768 (1991).
   PubMedGoogle Scholar
• Tan IB, Grabsch H, Toh HCet al. Comparing the classification precision and prognostic performance of an intrinsic gastric cancer signature with existing genomic signatures in six independent datasets. J. Clin. Oncol. 29(Suppl.), abstract 4025 (2011).
   Google Scholar
• Tan IB, Ivanova T, Lim KHet al. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology 141(2), 476–485, 485.e1 (2011).
   PubMed Web of Science ®Google Scholar